Jeisys Medical Inc
KOSDAQ:287410
Jeisys Medical Inc
Total Current Liabilities
Jeisys Medical Inc
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Total Current Liabilities
₩64.4B
|
CAGR 3-Years
63%
|
CAGR 5-Years
682%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Total Current Liabilities
₩142.8B
|
CAGR 3-Years
28%
|
CAGR 5-Years
31%
|
CAGR 10-Years
27%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Total Current Liabilities
₩44.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Total Current Liabilities
₩50B
|
CAGR 3-Years
2 454%
|
CAGR 5-Years
658%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Total Current Liabilities
₩8.9B
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Total Current Liabilities
₩3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jeisys Medical Inc
Glance View
Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.
See Also
What is Jeisys Medical Inc's Total Current Liabilities?
Total Current Liabilities
64.4B
KRW
Based on the financial report for Jun 30, 2024, Jeisys Medical Inc's Total Current Liabilities amounts to 64.4B KRW.
What is Jeisys Medical Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
682%
Over the last year, the Total Current Liabilities growth was 124%. The average annual Total Current Liabilities growth rates for Jeisys Medical Inc have been 63% over the past three years , 682% over the past five years .
